Phosphorylation of vasodilator-stimulated phosphoprotein Ser239 suppresses filopodia and invadopodia in colon cancer

International Journal of Cancer

Volumn 130, Issue 11, 2012, Pages 2539-2548

  Zuzga, David S ^a,b   Pelta Heller, Joshua ^a   Li, Peng ^a   Bombonati, Alessandro ^c   Waldman, Scott A ^a   Pitari, Giovanni M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b PACE UNIVERSITY   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

colorectal cancer; cyclic GMP; filopodia; guanylyl cyclase C; invadopodia; vasodilator stimulated phosphoprotein

Indexed keywords

CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; GUANYLATE CYCLASE; GUANYLATE CYCLASE C; SERINE; UNCLASSIFIED DRUG; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ARTICLE; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL ORGANELLE; CELL SHAPE; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; FILOPODIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; INVADOPODIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; CELL SHAPE; CELL SURFACE EXTENSIONS; COLLAGEN TYPE IV; COLONIC NEOPLASMS; GUANYLATE CYCLASE; HUMANS; MICROFILAMENT PROTEINS; NEOPLASM INVASIVENESS; PHOSPHOPROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84859161224     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26257     Document Type: Article

References (34)

1. Pitari GM, Li P, Lin JE, Zuzga D, Gibbons AV, Snook AE, Schulz S, Waldman SA,. The paracrine hormone hypothesis of colorectal cancer. Clin Pharmacol Ther 2007; 82: 441-7.
2. Steinbrecher KA, Tuohy TM, Heppner Goss K, Scott MC, Witte DP, Groden J, Cohen MB,. Expression of guanylin is downregulated in mouse and human intestinal adenomas. Biochem Biophys Res Commun 2000; 273: 225-30.
3. Notterman DA, Alon U, Sierk AJ, Levine AJ,. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 2001; 61: 3124-30.
4. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA,. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 2000; 52: 375-414.
5. Pitari GM, Di Guglielmo MD, Park J, Schulz S, Waldman SA,. Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells. Proc Natl Acad Sci USA 2001; 98: 7846-51.
6. Lin JE, Li P, Snook AE, Schulz S, Dasgupta A, Hyslop TM, Gibbons AV, Marszlowicz G, Pitari GM, Waldman SA,. The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling. Gastroenterology 2010; 138: 241-54.
7. Li P, Schulz S, Bombonati A, Palazzo JP, Hyslop TM, Xu Y, Barab AA, Siracusa LD, Pitari GM, Waldman SA,. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity. Gastroenterology 2007; 133: 599-607.
8. Deguchi A, Soh JW, Li H, Pamukcu R, Thompson WJ, Weinstein IB,. Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G. Mol Cancer Ther 2002; 1: 803-9.
9. Krause M, Dent EW, Bear JE, Loureiro JJ, Gertler FB,. Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol 2003; 19: 541-64.
10. Mejillano MR, Kojima S, Applewhite DA, Gertler FB, Svitkina TM, Borisy GG,. Lamellipodial versus filopodial mode of the actin nanomachinery: pivotal role of the filament barbed end. Cell 2004; 118: 363-73.
11. Butt E, Abel K, Krieger M, Palm D, Hoppe V, Hoppe J, Walter U,. cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J Biol Chem 1994; 269: 14509-17.
12. Blume C, Benz PM, Walter U, Ha J, Kemp BE, Renne T,. AMP-activated protein kinase impairs endothelial actin cytoskeleton assembly by phosphorylating vasodilator-stimulated phosphoprotein. J Biol Chem 2007; 282: 4601-12.
13. Benz PM, Blume C, Seifert S, Wilhelm S, Waschke J, Schuh K, Gertler F, Munzel T, Renne T,. Differential VASP phosphorylation controls remodeling of the actin cytoskeleton. J Cell Sci 2009; 122: 3954-65.
14. Lindsay SL, Ramsey S, Aitchison M, Renne T, Evans TJ,. Modulation of lamellipodial structure and dynamics by NO-dependent phosphorylation of VASP Ser239. J Cell Sci 2007; 120: 3011-21.
15. Yilmaz M, Christofori G,. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009; 28: 15-33.
16. Yamaguchi H, Condeelis J,. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 2007; 1773: 642-52.
17. Dostmann WR, Taylor MS, Nickl CK, Brayden JE, Frank R, Tegge WJ,. Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation. Proc Natl Acad Sci USA 2000; 97: 14772-7.
18. Bear JE, Gertler FB,. Ena/VASP: towards resolving a pointed controversy at the barbed end. J Cell Sci 2009; 122: 1947-53.
19. Steeg PS,. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006; 12: 895-904.
20. Linder S,. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol 2007; 17: 107-17.
21. Lubbe WJ, Zuzga DS, Zhou Z, Fu W, Pelta-Heller J, Muschel RJ, Waldman SA, Pitari GM,. Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9. Cancer Res 2009; 69: 3529-36.
22. Applewhite DA, Barzik M, Kojima S, Svitkina TM, Gertler FB, Borisy GG,. Ena/VASP proteins have an anti-capping independent function in filopodia formation. Mol Biol Cell 2007; 18: 2579-91.
23. Philippar U, Roussos ET, Oser M, Yamaguchi H, Kim HD, Giampieri S, Wang Y, Goswami S, Wyckoff JB, Lauffenburger DA, Sahai E, Condeelis JS, et al. A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev Cell 2008; 15: 813-28.
24. Han G, Fan B, Zhang Y, Zhou X, Wang Y, Dong H, Wei Y, Sun S, Hu M, Zhang J, Wei L,. Positive regulation of migration and invasion by vasodilator- stimulated phosphoprotein via Rac1 pathway in human breast cancer cells. Oncol Rep 2008; 20: 929-39.
25. Dertsiz L, Ozbilim G, Kayisli Y, Gokhan GA, Demircan A, Kayisli UA,. Differential expression of VASP in normal lung tissue and lung adenocarcinomas. Thorax 2005; 60: 576-81.
26. Hu LD, Zou HF, Zhan SX, Cao KM,. EVL (Ena/VASP-like) expression is up-regulated in human breast cancer and its relative expression level is correlated with clinical stages. Oncol Rep 2008; 19: 1015-20.
27. Weaver AM,. Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis 2006; 23: 97-105.
28. Stylli SS, Kaye AH, Lock P,. Invadopodia: at the cutting edge of tumour invasion. J Clin Neurosci 2008; 15: 725-37.
29. Wentworth JK, Pula G, Poole AW,. Vasodilator-stimulated phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase C-dependent and -independent mechanisms in thrombin-stimulated human platelets. Biochem J 2006; 393: 555-64.
30. Lebrand C, Dent EW, Strasser GA, Lanier LM, Krause M, Svitkina TM, Borisy GG, Gertler FB,. Critical role of Ena/VASP proteins for filopodia formation in neurons and in function downstream of netrin-1. Neuron 2004; 42: 37-49.
31. Gomez TM, Robles E,. The great escape; phosphorylation of Ena/VASP by PKA promotes filopodial formation. Neuron 2004; 42: 1-3.
32. Aszodi A, Pfeifer A, Ahmad M, Glauner M, Zhou XH, Ny L, Andersson KE, Kehrel B, Offermanns S, Fassler R,. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. EMBO J 1999; 18: 37-48.
33. Barzik M, Kotova TI, Higgs HN, Hazelwood L, Hanein D, Gertler FB, Schafer DA,. Ena/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins. J Biol Chem 2005; 280: 28653-62.
34. Yaroslavskiy BB, Zhang Y, Kalla SE, Garcia Palacios V, Sharrow AC, Li Y, Zaidi M, Wu C, Blair HC,. NO-dependent osteoclast motility: reliance on cGMP-dependent protein kinase I and VASP. J Cell Sci 2005; 118: 5479-87.